Time- and dose-related improvements in insulin sensitivity were similar to the temporal patterns of body weight loss with retatrutide in both the MASLD cohort reported here and in the full cohort of people with obesity 13
The average GLP-1 user surveyed saves $42 per month compared to their pre-GLP-1 spending, including the cost of the drug
Receptor Comparison# Weight Loss Efficacy# Retatrutide Phase 2 Results# The Phase 2 obesity trial (Jastreboff et al., NEJM 2023
How PlexusDx Supports a More Personalized Approach PlexusDx genetic insights into GLP1R, GIPR, MC4R, and FTO variants may help provide context for understanding why your tolerability profile differs from a friend or family member on the same medication
But if you would tell us, generally speaking, why do you think Medicare is looking into offering reduced-price GLP-1s to its recipients
If we use a comparator of diabetes, can you imagine telling someone: I want you to use the telehealth company and they will take an onboarding to find out about your diabetes